Lance Alstodt's most recent trade in BioRestorative Therapies Inc was a trade of 15,625 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Oct. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.60 per share. | 06 Oct 2025 | 15,625 | 187,497 | - | 1.6 | 25,000 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2025 | 11,719 | 11,719 | - | - | Warrant | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 791,885 | 791,885 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 18 Mar 2024 | 17,633 | 171,872 | - | 1.4 | 24,510 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 438,596 | 438,596 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.44 per share. | 25 Jul 2023 | 4,200 | 184,418 | - | 2.4 | 10,248 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.92 per share. | 20 Mar 2023 | 6,729 | 180,218 | - | 2.9 | 19,649 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 18 Feb 2023 | 374 | 186,947 | - | 3.0 | 1,118 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 106,762 | 106,762 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 01 Feb 2023 | 400 | 187,321 | - | 3.1 | 1,241 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.01 per share. | 27 Jan 2023 | 200 | 186,921 | - | 3.0 | 602 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 20 Jan 2023 | 100 | 186,721 | - | 3.2 | 317 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 20 Jan 2023 | 100 | 186,621 | - | 3.1 | 310 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.13 per share. | 18 Jan 2023 | 200 | 186,321 | - | 3.1 | 626 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 18 Jan 2023 | 100 | 186,421 | - | 3.1 | 310 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.09 per share. | 18 Jan 2023 | 100 | 186,521 | - | 3.1 | 309 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 09 Jan 2023 | 100 | 186,121 | - | 3.1 | 308 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.02 per share. | 23 Dec 2022 | 200 | 185,921 | - | 3.0 | 604 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 23 Dec 2022 | 100 | 186,021 | - | 3.0 | 299 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 07 Dec 2022 | 1,800 | 185,721 | - | 3.0 | 5,375 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 18 Nov 2022 | 1,000 | 183,921 | - | 2.9 | 2,877 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 293,479 | 293,479 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Nov 2022 | 293,479 | 0 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 42,059 | 42,059 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Nov 2022 | 42,059 | 0 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 22 Sep 2022 | 100 | 182,921 | - | 2.9 | 285 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 22 Sep 2022 | 100 | 182,821 | - | 3.0 | 299 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 12 Jul 2022 | 700 | 182,721 | - | 3.0 | 2,065 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 30 Jun 2022 | 1,100 | 182,021 | - | 3.1 | 3,408 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.73 per share. | 16 Jun 2022 | 600 | 180,921 | - | 3.7 | 2,238 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.68 per share. | 15 Jun 2022 | 700 | 180,321 | - | 3.7 | 2,578 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 14 Jun 2022 | 500 | 179,621 | - | 3.9 | 1,956 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.92 per share. | 13 Jun 2022 | 100 | 179,121 | - | 3.9 | 392 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 13 Jun 2022 | 100 | 179,021 | - | 4.0 | 398 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 08 Jun 2022 | 100 | 178,921 | - | 4.3 | 428 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 01 Jun 2022 | 200 | 178,821 | - | 4.6 | 920 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 26 May 2022 | 2,700 | 178,621 | - | 3.5 | 9,494 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.94 per share. | 02 May 2022 | 200 | 175,721 | - | 3.9 | 787 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 02 May 2022 | 200 | 175,921 | - | 4.0 | 792 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 12,438 | 175,521 | - | - | Common Stock | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 24 Jan 2022 | 1,470 | 163,083 | - | 3.4 | 4,998 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 05 Jan 2022 | 2,000 | 161,613 | - | 3.9 | 7,700 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 01 Dec 2021 | 799 | 159,613 | - | 5.5 | 4,395 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 23 Nov 2021 | 2,500 | 158,814 | - | 6 | 15,000 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 6.31 per share. | 22 Nov 2021 | 396 | 156,314 | - | 6.3 | 2,499 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 6.87 per share. | 16 Nov 2021 | 1,800 | 154,218 | - | 6.9 | 12,366 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 6.51 per share. | 16 Nov 2021 | 1,500 | 155,918 | - | 6.5 | 9,765 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 6.76 per share. | 16 Nov 2021 | 1,000 | 152,418 | - | 6.8 | 6,760 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Purchase of securities on an exchange or from another person at price $ 6.55 per share. | 16 Nov 2021 | 200 | 154,418 | - | 6.6 | 1,310 | Common Stock |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2021 | 293,479 | 0 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 293,479 | 293,479 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Lance Alstodt | Director, President, CEO, COB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 42,059 | 42,059 | - | - | Stock Option |